<DOC>
	<DOCNO>NCT00840801</DOCNO>
	<brief_summary>The objective study assess immunogenicity , safety interchangeability two different TBE vaccine child age 1-11 year , first second vaccination either FSME-IMMUN 0.25ml Junior Encepur 0.25ml Children third vaccination FSME-IMMUN 0.25 ml Junior , administer accord conventional schedule ( 0 , 28 360 day ) .</brief_summary>
	<brief_title>Immunogenicity , Safety Interchangeability Two Tbe Vaccines Administered According Conventional Schedule Children</brief_title>
	<detailed_description />
	<mesh_term>Encephalitis</mesh_term>
	<mesh_term>Encephalitis , Tick-Borne</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Male female child eligible participation study : age &gt; = 1 year ( 1st birthday ) 11 year ( last day 12th birthday ) screening ; parent / legal guardian provide write informed consent ; child provide write assent study accord age capacity understanding ; parents/guardians understand nature clinical study comply requirement protocol ( e.g. , completion Subject Diary , return followup visit ) ; generally healthy , ( i.e . physician would reservations vaccinate TBE vaccine outside scope clinical study ) ; provide negative pregnancy test result first medical examination ( subject female capable bearing child ) . Subjects exclude participation : history previous TBE vaccination ; history TBE infection ; history infection flaviviruses ; history vaccination yellow fever and/or Japanese B encephalitis ; history severe allergic reaction , particular know sensitivity allergy component vaccine ; suffer disease ( e.g . autoimmune disease ) undergo form treatment ( e.g . systemic corticosteroid ) expect influence immunological function ; receive blood product immunoglobulin within 90 day prior study entry ; know Human Immunodeficiency Virus ( HIV ) positive ( HIV test require specifically purpose study ) ; functional surgical asplenia ; rash dermatological condition injection site could interfere injection site reaction evaluation ; administer investigational product within six week prior study start concurrently participate another clinical study include administration investigational product ; pregnant breastfeeding ( female subject ) ; parents/legal guardian ( ) dependent relationship study investigator study team member . Dependent relationship include close relative ( i.e. , child grandchild , partner/spouse , sibling ) well employee investigator site conducting study . Subjects acute illness without elevate body temperature ( &gt; =37.5°C ) within 3 day prior schedule first vaccination vaccinate . Subjects may include repeat visit provide ( 1 ) illness resolve ( body temperature &lt; 37.5 °C ) , ( 2 ) repeat visit 14 calendar day Screening Visit , ( 3 ) center still open recruitment . If subject receive antipyretic within 4 hour prior schedule time vaccination , vaccination perform later date , long center still open recruitment . Subjects receive live vaccine within 4 week inactivate vaccine within 2 week prior schedule first study vaccination vaccinate interval 4 2 week , respectively , pass , provide center still open recruitment . If subject bitten tick within 4 week prior schedule first second vaccination , vaccination must postpone interval 4 week pass .</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>